• Consensus Rating: Moderate Buy
  • Consensus Price Target: $21.86
  • Forecasted Upside: 25.47%
  • Number of Analysts: 7
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$17.42
▲ +0.08 (0.46%)

This chart shows the closing price for IMAX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New IMAX Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IMAX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IMAX

Analyst Price Target is $21.86
▲ +25.47% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for IMAX in the last 3 months. The average price target is $21.86, with a high forecast of $30.00 and a low forecast of $13.00. The average price target represents a 25.47% upside from the last price of $17.42.

This chart shows the closing price for IMAX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 7 contributing investment analysts is to moderate buy stock in IMAX. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
1/21/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
4/21/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
7/20/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
10/18/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
1/16/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
4/15/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
6/14/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
7/14/2024

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/8/2024B. RileyBoost TargetBuy ➝ Buy$27.00 ➝ $30.00Low
6/21/2024WedbushReiterated RatingOutperform$22.00Low
6/20/2024BenchmarkReiterated RatingBuy ➝ Buy$22.00 ➝ $22.00Low
6/17/2024Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00Low
4/26/2024BenchmarkReiterated RatingBuy ➝ Buy$22.00Low
4/26/2024WedbushReiterated RatingOutperform ➝ Outperform$22.00Low
4/22/2024Barrington ResearchReiterated RatingOutperform ➝ Outperform$24.00 ➝ $24.00Low
4/18/2024WedbushReiterated RatingOutperform ➝ Outperform$22.00Low
4/16/2024BenchmarkReiterated RatingBuy ➝ Buy$22.00Low
4/10/2024WedbushReiterated RatingOutperform ➝ Outperform$22.00Low
4/10/2024BenchmarkReiterated RatingBuy ➝ Buy$22.00Low
3/4/2024WedbushReiterated RatingOutperform ➝ Outperform$22.00Low
2/28/2024Barrington ResearchReiterated RatingOutperform ➝ Outperform$24.00Low
2/23/2024WedbushReiterated RatingOutperform ➝ Outperform$22.00Low
2/13/2024Rosenblatt SecuritiesLower TargetBuy ➝ Buy$30.00 ➝ $25.00Low
2/6/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$20.00 ➝ $17.00Low
1/18/2024BenchmarkLower TargetBuy ➝ Buy$24.00 ➝ $22.00Low
1/11/2024The Goldman Sachs GroupLower TargetSell ➝ Sell$15.00 ➝ $13.00Low
1/2/2024B. RileyLower TargetBuy ➝ Buy$27.00 ➝ $21.00Low
12/5/2023Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$30.00Low
10/26/2023WedbushReiterated RatingOutperform$26.00Low
10/18/2023WedbushReiterated RatingOutperform$26.00Low
10/10/2023Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$30.00Low
10/9/2023BenchmarkBoost TargetBuy ➝ Buy$23.00 ➝ $24.00Low
8/25/2023Rosenblatt SecuritiesBoost TargetBuy ➝ Buy$27.00 ➝ $30.00Low
8/18/2023Rosenblatt SecuritiesBoost TargetBuy ➝ Buy$27.00 ➝ $30.00Low
7/28/2023Barrington ResearchReiterated RatingOutperform ➝ Outperform$24.00Low
7/27/2023WedbushReiterated RatingOutperform ➝ Outperform$26.00Low
7/27/2023Rosenblatt SecuritiesBoost TargetBuy$27.00 ➝ $30.00Low
7/20/2023WedbushReiterated RatingOutperform ➝ Outperform$26.00Low
4/28/2023Rosenblatt SecuritiesBoost Target$25.00 ➝ $27.00Low
4/28/2023B. RileyBoost Target$26.00 ➝ $27.00Low
4/21/2023Barrington ResearchBoost TargetOutperform$22.00 ➝ $24.00Low
4/10/2023B. RileyBoost TargetBuy$23.00 ➝ $26.00Low
4/5/2023Rosenblatt SecuritiesReiterated RatingBuy$25.00Low
2/28/2023The Goldman Sachs GroupBoost TargetSell$12.00 ➝ $14.00Low
2/24/2023Barrington ResearchBoost Target$20.00 ➝ $22.00Low
2/23/2023JPMorgan Chase & Co.Boost TargetNeutral$16.00 ➝ $19.00Low
2/23/2023Barrington ResearchReiterated RatingOutperform$20.00Low
2/23/2023Rosenblatt SecuritiesBoost TargetBuy$22.00 ➝ $25.00Low
2/13/2023Roth CapitalReiterated RatingBuyLow
1/17/2023Rosenblatt SecuritiesReiterated RatingBuy$22.00Low
12/5/2022B. RileyBoost TargetBuy$20.00 ➝ $23.00Low
11/1/2022WedbushReiterated RatingOutperform$20.00Low
11/1/2022JPMorgan Chase & Co.Lower TargetNeutral$18.00 ➝ $16.00Low
11/1/2022Wells Fargo & CompanyLower TargetOverweight$26.00 ➝ $21.00Low
10/12/2022B. RileyLower TargetBuy$25.00 ➝ $20.00Low
10/10/2022JPMorgan Chase & Co.Lower TargetNeutral$19.00 ➝ $18.00Low
10/6/2022BenchmarkLower TargetBuy$25.00 ➝ $21.00Low
7/18/2022BenchmarkLower TargetBuy$28.00 ➝ $25.00Low
6/21/2022B. RileyLower TargetBuy$30.00 ➝ $25.00Low
5/23/2022Rosenblatt SecuritiesInitiated CoverageBuy$25.00High
5/2/2022Barrington ResearchLower Target$25.00 ➝ $20.00High
4/29/2022Barrington ResearchReiterated RatingBuy$25.00Medium
2/24/2022BenchmarkReiterated RatingBuy ➝ Buy$28.00Medium
10/29/2021Barrington ResearchBoost TargetOutperform$22.00 ➝ $25.00High
10/22/2021Wells Fargo & CompanyInitiated CoverageOverweight$27.00High
10/11/2021B. RileyBoost TargetOutperform ➝ Buy$28.00 ➝ $30.00High
8/11/2021WedbushReiterated RatingBuy$26.00Medium
7/29/2021Barrington ResearchLower TargetOutperform$27.00 ➝ $22.00High
7/28/2021Barrington ResearchReiterated RatingBuy$27.00Medium
7/28/2021JPMorgan Chase & Co.Lower TargetNeutral$24.00 ➝ $20.00High
7/26/2021Colliers SecuritiesReiterated RatingBuy$22.00High
6/2/2021The Goldman Sachs GroupDowngradeNeutral ➝ Sell$19.60 ➝ $18.60High
5/24/2021BenchmarkBoost TargetBuy$24.00 ➝ $25.00Medium
4/30/2021MacquarieBoost TargetOutperform$25.00 ➝ $30.00High
4/29/2021WedbushUpgradeNeutral ➝ Outperform$22.00 ➝ $26.00N/A
4/23/2021WedbushUpgradeNeutral ➝ Outperform$22.00 ➝ $26.00Low
3/16/2021B. RileyReiterated RatingBuy$28.00High
3/9/2021Barrington ResearchBoost Target$25.00 ➝ $27.00Low
3/5/2021MacquarieBoost TargetPositive ➝ Outperform$24.00 ➝ $25.00High
3/5/2021BenchmarkBoost TargetHold ➝ Buy$22.00 ➝ $24.00High
3/1/2021WedbushBoost TargetNeutral$14.00 ➝ $22.00Low
2/1/2021MKM PartnersBoost TargetBuy$18.00 ➝ $25.00Low
1/26/2021B. RileyBoost TargetUnderperform$26.00 ➝ $28.00High
1/25/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral$15.60 ➝ $17.90High
12/29/2020B. RileyBoost TargetPositive ➝ Buy$18.00 ➝ $26.00N/A
12/21/2020B. RileyReiterated RatingBuy$18.00Low
10/12/2020B. RileyLower Target$21.00 ➝ $18.00High
9/4/2020B. RileyBoost Target$18.00 ➝ $21.00Low
9/2/2020Barrington ResearchBoost TargetOutperform$15.00 ➝ $18.00Medium
9/1/2020The Goldman Sachs GroupBoost Target$14.00 ➝ $16.00Low
7/29/2020Barrington ResearchReiterated RatingBuy$15.00High
7/29/2020B. RileyReiterated RatingBuy$18.00High
7/24/2020WedbushInitiated CoverageHold$14.00Low
7/20/2020Barrington ResearchReiterated RatingOutperformHigh
7/16/2020B. RileyReiterated RatingBuy$18.00High
7/15/2020The Goldman Sachs GroupInitiated CoverageBuy$14.00High
7/13/2020MKM PartnersLower TargetBuy$20.00 ➝ $18.00High
5/1/2020B. RileyReiterated RatingBuy$19.00Low
4/30/2020Barrington ResearchReiterated RatingBuy$15.00Low
4/28/2020BenchmarkUpgradeHold ➝ Buy$14.00High
4/24/2020WedbushDowngradeOutperform ➝ Neutral$25.00 ➝ $12.00Low
4/15/2020MKM PartnersLower TargetBuy$24.00 ➝ $20.00Medium
4/2/2020B. RileyReiterated RatingBuy$19.00High
3/24/2020Barrington ResearchReiterated RatingOutperform$20.00 ➝ $15.00High
3/18/2020B. RileyLower TargetBuy$26.00 ➝ $19.00High
3/17/2020BenchmarkDowngradeBuy ➝ HoldHigh
3/17/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$22.00 ➝ $15.00High
2/24/2020Barrington ResearchLower TargetOutperform$24.00 ➝ $20.00High
2/20/2020WedbushBoost TargetOutperform$22.00 ➝ $25.00High
2/12/2020B. RileyReiterated RatingBuy$30.00 ➝ $26.00Low
2/4/2020MKM PartnersLower TargetBuy$24.00High
2/3/2020WedbushReiterated RatingOutperform$28.00 ➝ $22.00Low
1/29/2020BenchmarkLower TargetBuy$28.00 ➝ $20.00High
12/5/2019B. RileyReiterated RatingBuy$30.00Low
11/19/2019MKM PartnersReiterated RatingBuy$28.00Low
11/1/2019WedbushReiterated RatingHold ➝ Buy$28.00Low
10/21/2019WedbushSet TargetBuy$28.00Low
10/15/2019The Goldman Sachs GroupSet TargetHold$23.00Low
9/10/2019B. RileySet TargetBuy$34.00High
7/31/2019WedbushReiterated RatingOutperform$28.00Low
7/16/2019WedbushReiterated RatingBuy$28.00Low
(Data available from 7/15/2019 forward)

News Sentiment Rating

0.89 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 7 very positive mentions
  • 25 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
12/18/2023
  • 9 very positive mentions
  • 26 positive mentions
  • 6 negative mentions
  • 3 very negative mentions
1/17/2024
  • 7 very positive mentions
  • 24 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
2/16/2024
  • 24 very positive mentions
  • 58 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
3/17/2024
  • 11 very positive mentions
  • 47 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
4/16/2024
  • 20 very positive mentions
  • 38 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
5/16/2024
  • 10 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
6/15/2024
  • 8 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/15/2024

Current Sentiment

  • 8 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
IMAX logo
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies. It also offers preventative and emergency maintenance services and quality monitoring to the IMAX network; film post-production services; and IMAX film and digital cameras to content creators. In addition, the company engages in the distribution of large-format documentary films to institutional theaters, as well as live performances and interactive events with artists and creators; after-market sales of IMAX System parts and 3D glasses; sale or lease of IMAX theater systems; provision of management services to three other theaters, as well as production advice and technical assistance to documentary and Hollywood filmmakers; and rental of company's proprietary 2D and 3D large-format film cameras. The company markets its theater systems through a direct sales force and marketing staff to science and natural history museums, zoos, aquaria, and other educational and cultural centers, as well as theme parks, private home theaters, tourist destination sites, fairs, and expositions. It offers its services under the IMAX, IMAX 3D, Experience It In IMAX, The IMAX Experience, DMR, Filmed For IMAXTM, IMAX Live, IMAX Enhanced, and SSIMWAVE. The company operates a network of IMAX systems comprising commercial multiplexes, commercial destinations, and institutional locations in 90 countries and territories. IMAX Corporation was founded in 1967 and is headquartered in Mississauga, Canada.
Read More

Today's Range

Now: $17.42
Low: $17.17
High: $17.58

50 Day Range

MA: $16.55
Low: $15.11
High: $17.71

52 Week Range

Now: $17.42
Low: $13.20
High: $20.70

Volume

471,000 shs

Average Volume

788,198 shs

Market Capitalization

$916.64 million

P/E Ratio

36.29

Dividend Yield

N/A

Beta

1.26

Frequently Asked Questions

What sell-side analysts currently cover shares of IMAX?

The following Wall Street analysts have issued research reports on IMAX in the last twelve months: B. Riley, Barrington Research, Benchmark Co., JPMorgan Chase & Co., Rosenblatt Securities, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, and Wedbush.
View the latest analyst ratings for IMAX.

What is the current price target for IMAX?

7 Wall Street analysts have set twelve-month price targets for IMAX in the last year. Their average twelve-month price target is $21.86, suggesting a possible upside of 25.5%. B. Riley has the highest price target set, predicting IMAX will reach $30.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $13.00 for IMAX in the next year.
View the latest price targets for IMAX.

What is the current consensus analyst rating for IMAX?

IMAX currently has 1 sell rating, 1 hold rating and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for IMAX.

What other companies compete with IMAX?

Other companies that are similar to IMAX include Eastman Kodak, GoPro, Liberty Live Group, Steven Madden and YETI. Learn More about companies similar to IMAX.

How do I contact IMAX's investor relations team?

IMAX's physical mailing address is 2525 Speakman Drive, Mississauga A6, L5K 1B1. The company's listed phone number is (905) 403-6500 and its investor relations email address is [email protected]. The official website for IMAX is www.imax.com. Learn More about contacing IMAX investor relations.